Scott W. Stoker
About
In The Last Decade
Scott W. Stoker
20 papers receiving 716 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 425
- Surgery 317
- Cardiology and Cardiovascular Medicine 187
- Physiology 119
- Endocrinology, Diabetes and Metabolism 107
Countries citing papers authored by Scott W. Stoker
This map shows the geographic impact of Scott W. Stoker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Stoker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Stoker more than expected).
Fields of papers citing papers by Scott W. Stoker
This network shows the impact of papers produced by Scott W. Stoker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Stoker. The network helps show where Scott W. Stoker may publish in the future.
Co-authorship network of co-authors of Scott W. Stoker
This figure shows the co-authorship network connecting the top 25 collaborators of Scott W. Stoker. A scholar is included among the top collaborators of Scott W. Stoker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott W. Stoker. Scott W. Stoker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 23 | |
| 3 | 7 | |
| 4 | 40 | |
| 5 | 34 | |
| 6 | 25 | |
| 7 | 43 | |
| 8 | 29 | |
| 9 | 29 | |
| 10 | 7 | |
| 11 | 17 | |
| 12 | 81 | |
| 13 | 24 | |
| 14 | 71 | |
| 15 | 11 | |
| 16 | 41 | |
| 17 | 42 | |
| 18 | Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. | 12 |
| 19 | 6 | |
| 20 | 186 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.